|Last Price||Today's Change||52-Week Range||Trading Volume|
|51.79||1.22 (+2.41%)||41.99 - 80.42||72.4 thousand (Below Avg)|
Market data as of 1:00PM 12/24/14. Quotes are delayed by at least 15 min.
Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus
12/19/2014 11:30 AM ET
Ligand Provides Highlights from Today’s Analyst Day Event
11/18/2014 11:41 AM ET